Page 5 - James William Burns News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James william burns. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James William Burns Today - Breaking & Trending Today

Agios Pharmaceuticals (NASDAQ:AGIO) Price Target Cut to $32.00 by Analysts at JPMorgan Chase & Co.

Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its price target reduced by JPMorgan Chase & Co. from $33.00 to $32.00 in a research report released on Monday, Benzinga reports. They currently have a neutral rating on the biopharmaceutical company’s stock. Other analysts have also issued research reports about the stock. SVB Securities decreased their price […] ....

United States , James William Burns , Theodore James Jr , Securities Exchange Commission , Envestnet Asset Management Inc , Agios Pharmaceuticals Company Profile , Agios Pharmaceuticals Price Performance , Fisher Asset Management , News Ratings For Agios Pharmaceuticals Daily , Jpmorgan Chase Co , Hedge Funds Weigh In On Agios Pharmaceuticals , American International Group Inc , Agios Pharmaceuticals Inc , International Biotechnology Trust , Agios Pharmaceuticals , Free Report , Get Free Report , Exchange Commission , Theodore James , Asset Management , Biotechnology Trust , American International Group , International Group , Agios Pharmaceuticals Daily , Nasdaq Agio , Lower Price Target ,

Agios Pharmaceuticals (NASDAQ:AGIO) Releases Earnings Results, Beats Estimates By $0.09 EPS

Agios Pharmaceuticals (NASDAQ:AGIO) Releases Earnings Results, Beats Estimates By $0.09 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , Jacqualyna Fouse , James William Burns , Agios Pharmaceuticals Inc , Agios Pharmaceuticals , Hong Kong Ltd , News Ratings For Agios Pharmaceuticals Daily , Sei Investments Co , Lazard Asset Management , Agios Pharmaceuticals Company Profile , Agios Pharmaceuticals Trading Down , Institutional Trading Of Agios Pharmaceuticals , Securities Exchange Commission , Earnings History For Agios Pharmaceuticals , Tower Research Capital , Envestnet Asset Management Inc , Get Free Report , Pharmaceuticals Trading Down , Director Jacqualyn , Exchange Commission , Kong Ltd , Research Capital , Asset Management , Sei Investments , Agios Pharmaceuticals Daily ,

Agios Pharmaceuticals (NASDAQ:AGIO) Posts Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($1.51) EPS for the quarter, beating the consensus estimate of ($1.60) by $0.09, Briefing.com reports. Agios Pharmaceuticals had a negative return on equity of 19.77% and a negative net margin of 1,042.56%. The firm had revenue of […] ....

Theodore James Jr , James William Burns , Dimensional Fund Advisors , Agios Pharmaceuticals Inc , Insider Transactions At Agios Pharmaceuticals , Agios Pharmaceuticals Trading Down , Earnings History For Agios Pharmaceuticals , First Trust Advisors , News Ratings For Agios Pharmaceuticals Daily , Blackrock Inc , Vanguard Group Inc , Agios Pharmaceuticals Company Profile , Agios Pharmaceuticals , Get Free Report , Pharmaceuticals Trading Down , Theodore James , Street Corp , Fund Advisors , Trust Advisors , Agios Pharmaceuticals Daily , Nasdaq Agio ,

Agios Pharmaceuticals (NASDAQ:AGIO) Shares Down 4.1%

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) dropped 4.1% during trading on Thursday . The company traded as low as $27.94 and last traded at $28.00. Approximately 334,693 shares traded hands during mid-day trading, a decline of 34% from the average daily volume of 505,727 shares. The stock had previously closed at $29.19. […] ....

James William Burns , Brian Goff , Agios Pharmaceuticals Stock Performance , Agios Pharmaceuticals , Managers Group , News Ratings For Agios Pharmaceuticals Daily , Securities Exchange Commission , Capital Fund Management , Arrowmark Colorado Holdings , Algert Global , Proshare Advisors , Hedge Funds Weigh In On Agios Pharmaceuticals , Agios Pharmaceuticals Inc , Free Report , Exchange Commission , Mark Colorado Holdings , Share Advisors , Agios Pharmaceuticals Daily ,

Insider Selling: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Insider Sells 1,707 Shares of Stock

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) insider James William Burns sold 1,707 shares of the firm’s stock in a transaction dated Friday, June 30th. The stock was sold at an average price of $28.36, for a total value of $48,410.52. Following the transaction, the insider now owns 30,285 shares in the company, valued at […] ....

Hong Kong , James William Burns , Institutional Investors Weigh In On Agios Pharmaceuticals , Agios Pharmaceuticals , News Ratings For Agios Pharmaceuticals Daily , Agios Pharmaceuticals Inc , Lazard Asset Management , Agios Pharmaceuticals Company Profile , Tower Research Capital , Hong Kong Ltd , Securities Exchange Commission , Quarter For Agios Pharmaceuticals , Sg Americas Securities , Agios Pharmaceuticals Stock Performance , Free Report , Exchange Commission , Kong Ltd , Research Capital , Asset Management , Agios Pharmaceuticals Daily , Nasdaq Agio , Insider Trading , Nsider Trades ,